COVAXIN (BBV152) booster dose study shows Promising Results
The phase 2, double-blind, randomised controlled COVAXIN trial demonstrated long-term safety with no serious adverse events
Read - https://t.co/0uw1xqcFAa@MoHFW_INDIA @tapasjournalist @PIB_India @MIB_India pic.twitter.com/Dj64icmqBa— DD News (@DDNewslive) January 8, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


